Refine
Year of publication
Document Type
- Preprint (578)
- Article (347)
- Working Paper (4)
Has Fulltext
- yes (929)
Is part of the Bibliography
- no (929)
Keywords
- Heavy Ion Experiments (21)
- Hadron-Hadron Scattering (11)
- Hadron-Hadron scattering (experiments) (11)
- Heavy-ion collision (5)
- Jets (5)
- Collective Flow (4)
- Heavy Quark Production (4)
- Quark-Gluon Plasma (4)
- EEG (3)
- Jets and Jet Substructure (3)
- MRI (3)
- Atherosclerosis (2)
- Atmospheric science (2)
- Biomarker (2)
- Bone density (2)
- COVID-19 (2)
- Climate change (2)
- Experimental models of disease (2)
- Experimental nuclear physics (2)
- Experimental particle physics (2)
- High-throughput screening (2)
- Lepton-Nucleon Scattering (experiments) (2)
- Oncology (2)
- Osteoporosis (2)
- Particle Correlations and Fluctuations (2)
- Particle and resonance production (2)
- Particle correlations and fluctuations (2)
- QCD (2)
- Quark Gluon Plasma (2)
- Quarkonium (2)
- aging (2)
- alpha power (2)
- risk factors (2)
- white matter hyperintensity (2)
- ALICE detector (1)
- Accelerators & Beams (1)
- Accelerators & storage rings (1)
- Aging (1)
- Alpha power (1)
- Alternative splicing (1)
- Analysis and statistical methods (1)
- Anatomic competence (1)
- Anti-nuclei (1)
- Antiviral therapy (1)
- Arthroscopy (1)
- Atmospheric chemistry (1)
- Atomic & molecular beams (1)
- Atomic, Molecular & Optical (1)
- Beam loss (1)
- Bone diseases, Metabolic (1)
- Boosted Jets (1)
- Brain metastasis (1)
- Breast cancer (1)
- CAC-DRS Score (1)
- CD74 (1)
- CT dual-energy computed tomography (1)
- CVD biomarker (1)
- CXCR4 (1)
- Calorimeters (1)
- Cancer detection and diagnosis (1)
- Cancer genomics (1)
- Canopy height model (1)
- Cardiovascular diseases (1)
- Charge-transfer collisions (1)
- Chronic hepatitis (1)
- Circular accelerators (1)
- Cirrhosis (1)
- Clinical frailty scale (1)
- Coagulation (1)
- Collective Flow, (1)
- Communicable diseases (1)
- Computational models (1)
- Computed Tomography (1)
- Coronary Heart Disease (1)
- Coronary Plaque Burden (1)
- Critical pathway (1)
- Crohn’s disease (1)
- Data processing methods (1)
- Data sharing (1)
- Diagnostic markers (1)
- Diagnostic techniques and procedures (1)
- Dual-energy computed tomography (1)
- Education (1)
- Electron-pion identification (1)
- Electronic transitions (1)
- Electroweak interaction (1)
- Energy modelling (1)
- European Union (1)
- Fibre/foam sandwich radiator (1)
- Frailty (1)
- Genetic causes of cancer (1)
- Genetic testing (1)
- Germany (1)
- HLA class II (1)
- HLA peptidome (1)
- HNSCC (1)
- Hadron-Hadron Scattering Heavy (1)
- Hadron-hadron interactions (1)
- Hard Scattering (1)
- Head and neck cancer (1)
- Health risk analysis (1)
- Heavy Ion Experiment (1)
- Heavy Ions (1)
- Heavy-Ion Collision (1)
- Heavy-ion detectors (1)
- Hepatitis C virus (1)
- Histology (1)
- Human genetics (1)
- Immunology (1)
- Infection control (1)
- Inflammation (1)
- Intensive care outcome (1)
- Ionisation energy loss (1)
- Italy (1)
- Jet Physics (1)
- Jet Substructure (1)
- Knee joint (1)
- LHC (1)
- Large detector systems for particle and astroparticle physics (1)
- Loco-regional control (1)
- Low & intermediate-energy accelerators (1)
- Machine learning (1)
- Material budget (1)
- Mechanisms of disease (1)
- Medical (1)
- Medical education (1)
- Mortality (1)
- Multi-Parton Interactions (1)
- Multi-wire proportional drift chamber (1)
- Musculoskeletal ultrasound (1)
- Myocardial infarction (1)
- Myocardial injury (1)
- NOD2 (1)
- Neural network (1)
- Nuclear astrophysics (1)
- Nuclear physics of explosive environments (1)
- Nuclear reactions (1)
- Open data (1)
- Open source (1)
- Osteoporotic fractures (1)
- Ovarian cancer (1)
- Particle and Resonance Production (1)
- Patient isolation (1)
- Pb–Pb collisions (1)
- Performance of High Energy Physics Detectors (1)
- Phantoms (imaging) (1)
- Photon counting (1)
- Postoperative radiochemotherapy (1)
- Prognostic (1)
- Properties of Hadrons (1)
- Protease inhibitor therapy (1)
- Quark Deconfinement (1)
- Quark Production (1)
- Quark gluon plasma (1)
- RNA (1)
- RNA-binding proteins (1)
- Radiative capture (1)
- Radiomics (1)
- Randomized controlled trial (1)
- Relativistic heavy-ion collisions (1)
- Respiratory signs and symptoms (1)
- Resting-state (1)
- Reverse transcription polymerase chain reaction (1)
- SARS-CoV-2 (1)
- SARS-CoV-2 Pneumonia (1)
- SDF-1 (1)
- Shoulder joint (1)
- Specimen preparation and treatment (1)
- Stroke (1)
- Students (1)
- Sweden (1)
- TR (1)
- Tomography (x-ray computed) (1)
- Tracking (1)
- Transition radiation detector (1)
- Translational research (1)
- Trauma (1)
- Trichuris suis ova (1)
- Trigger (1)
- Tumor infiltrating lymphocytes (1)
- UAV (1)
- VIP1 (1)
- Validation (1)
- Vector Boson Production (1)
- Viral load (1)
- White matter hyperintensity (1)
- X-ray crystallography (1)
- Xenon-based gas mixture (1)
- amino acids (1)
- aortic stenosis (1)
- cardiac remodeling (1)
- clinical immunology (1)
- dE/dx (1)
- detector (1)
- drone (1)
- experimental results (1)
- fine spatial resolution remote sensing (1)
- global change (1)
- habitat destruction (1)
- heart failure (1)
- heavy ion experiments (1)
- helminths (1)
- image-based risk modelling (1)
- immunosuppression (1)
- infection (1)
- innate immunity (1)
- land use (1)
- lymphocytes (1)
- machine learning (1)
- mortality risk (1)
- neutralizing antibodies (1)
- personalised therapy (1)
- plant height (1)
- pneumocystis (1)
- quark gluon plasma (1)
- radiation oncology (1)
- radiomic (1)
- rats (1)
- renal transplantation (1)
- resting-state (1)
- risk factor progression (1)
- spike protein (1)
- structure-from-motion photogrammetry (1)
- survival (1)
- transplantation (1)
- variants of concern (1)
- x-ray techniques (1)
Institute
- Physik (874)
- Frankfurt Institute for Advanced Studies (FIAS) (814)
- Informatik (779)
- Medizin (29)
- Geowissenschaften (8)
- ELEMENTS (6)
- Geowissenschaften / Geographie (5)
- Biodiversität und Klima Forschungszentrum (BiK-F) (4)
- Informatik und Mathematik (3)
- Senckenbergische Naturforschende Gesellschaft (3)
Activated SUMOylation restricts MHC class I antigen presentation to confer immune evasion in cancer
(2022)
Activated SUMOylation is a hallmark of cancer. Starting from a targeted screening for SUMO-regulated immune evasion mechanisms, we identified an evolutionarily conserved function of activated SUMOylation, which attenuated the immunogenicity of tumor cells. Activated SUMOylation allowed cancer cells to evade CD8+ T cell–mediated immunosurveillance by suppressing the MHC class I (MHC-I) antigen-processing and presentation machinery (APM). Loss of the MHC-I APM is a frequent cause of resistance to cancer immunotherapies, and the pharmacological inhibition of SUMOylation (SUMOi) resulted in reduced activity of the transcriptional repressor scaffold attachment factor B (SAFB) and induction of the MHC-I APM. Consequently, SUMOi enhanced the presentation of antigens and the susceptibility of tumor cells to CD8+ T cell–mediated killing. Importantly, SUMOi also triggered the activation of CD8+ T cells and thereby drove a feed-forward loop amplifying the specific antitumor immune response. In summary, we showed that activated SUMOylation allowed tumor cells to evade antitumor immunosurveillance, and we have expanded the understanding of SUMOi as a rational therapeutic strategy for enhancing the efficacy of cancer immunotherapies.
We present the charged-particle pseudorapidity density in Pb–Pb collisions at √sNN = 5.02 TeV in centrality classes measured by ALICE. The measurement covers a wide pseudorapidity range from −3.5 to 5, which is sufficient for reliable estimates of the total number of charged particles produced in the collisions. For the most central (0–5%) collisions we find 21 400 ± 1 300, while for the most peripheral (80–90%) we find 230 ± 38. This corresponds to an increase of (27 ± 4)% over the results at √sNN = 2.76 TeV previously reported by ALICE. The energy dependence of the total number of charged particles produced in heavy-ion collisions is found to obey a modified power-law like behaviour. The chargedparticle pseudorapidity density of the most central collisions is compared to model calculations — none of which fully describes the measured distribution. We also present an estimate of the rapidity density of charged particles. The width of that distribution is found to exhibit a remarkable proportionality to the beam rapidity, independent of the collision energy from the top SPS to LHC energies.
Two-particle angular correlations were measured in pp collisions at s√=7 TeV for pions, kaons, protons, and lambdas, for all particle/anti-particle combinations in the pair. Data for mesons exhibit an expected peak dominated by effects associated with mini-jets and are well reproduced by general purpose Monte Carlo generators. However, for baryon–baryon and anti-baryon–anti-baryon pairs, where both particles have the same baryon number, a near-side anti-correlation structure is observed instead of a peak. This effect is interpreted in the context of baryon production mechanisms in the fragmentation process. It currently presents a challenge to Monte Carlo models and its origin remains an open question.
Background: In intensive care units (ICU) octogenarians become a routine patients group with aggravated therapeutic and diagnostic decision-making. Due to increased mortality and a reduced quality of life in this high-risk population, medical decision-making a fortiori requires an optimum of risk stratification. Recently, the VIP-1 trial prospectively observed that the clinical frailty scale (CFS) performed well in ICU patients in overall-survival and short-term outcome prediction. However, it is known that healthcare systems differ in the 21 countries contributing to the VIP-1 trial. Hence, our main focus was to investigate whether the CFS is usable for risk stratification in octogenarians admitted to diversified and high tech German ICUs.
Methods: This multicentre prospective cohort study analyses very old patients admitted to 20 German ICUs as a sub-analysis of the VIP-1 trial. Three hundred and eight patients of 80 years of age or older admitted consecutively to participating ICUs. CFS, cause of admission, APACHE II, SAPS II and SOFA scores, use of ICU resources and ICU- and 30-day mortality were recorded. Multivariate logistic regression analysis was used to identify factors associated with 30-day mortality.
Results: Patients had a median age of 84 [IQR 82–87] years and a mean CFS of 4.75 (± 1.6 standard-deviation) points. More than half of the patients (53.6%) were classified as frail (CFS ≥ 5). ICU-mortality was 17.3% and 30-day mortality was 31.2%. The cause of admission (planned vs. unplanned), (OR 5.74) and the CFS (OR 1.44 per point increase) were independent predictors of 30-day survival.
Conclusions: The CFS is an easy determinable valuable tool for prediction of 30-day ICU survival in octogenarians, thus, it may facilitate decision-making for intensive care givers in Germany.
Trial registration: The VIP-1 study was retrospectively registered on ClinicalTrials.gov (ID: NCT03134807) on May 1, 2017.
We have identified a mistake in how Fig. 1 is referenced in the text of the article Eur. Phys. J. C 77 (2017) no. 8, 569 which affected three paragraphs of the results section. The corrected three paragraphs as well as the unmodified accompanying figure are reproduced in this document with the correct labeling.
In addition, an editing issue led to a missing acknowledgements section. The missing section is reproduced at the end of this document in the manner in which it should have appeared in the published article.
G-protein-coupled receptor (GPCR) expression is extensively studied in bulk cDNA, but heterogeneity and functional patterning of GPCR expression in individual vascular cells is poorly understood. Here, we perform a microfluidic-based single-cell GPCR expression analysis in primary smooth muscle cells (SMC) and endothelial cells (EC). GPCR expression is highly heterogeneous in all cell types, which is confirmed in reporter mice, on the protein level and in human cells. Inflammatory activation in murine models of sepsis or atherosclerosis results in characteristic changes in the GPCR repertoire, and we identify functionally relevant subgroups of cells that are characterized by specific GPCR patterns. We further show that dedifferentiating SMC upregulate GPCRs such as Gpr39, Gprc5b, Gprc5c or Gpr124, and that selective targeting of Gprc5b modulates their differentiation state. Taken together, single-cell profiling identifies receptors expressed on pathologically relevant subpopulations and provides a basis for the development of new therapeutic strategies in vascular diseases.
SDF-1/CXCR4 expression in head and neck cancer and outcome after postoperative radiochemotherapy
(2017)
Introduction: Outcome after postoperative radiochemotherapy (RT-CT) for patients with advanced head and neck squamous cell carcinomas (HNSCC) remains unsatisfactory, especially among those with HPV negative tumours. Therefore, new biomarkers are needed to further define subgroups for individualised therapeutic approaches. Preclinical and first clinical observations showed that the chemokine receptor CXCR4 and its ligand SDF-1 (CXCL12) play an important role in tumour cell proliferation, survival, cancer progression, metastasis and treatment resistance. However, the data on the prognostic value of SDF-1/CXCR4 expression for HNSCC are conflicting. The aim of our hypothesis-generating study was to retrospectively explore the prognostic potential of SDF-1/CXCR4 in a well-defined cohort of HNSCC patients collected within the multicenter biomarker study of the German Cancer Consortium Radiation Oncology Group (DKTK-ROG).
Material and methods: Patients with stage III and IVA HNSCC of the oral cavity, oropharynx and hypopharynx were treated with resection and adjuvant radiotherapy (RT) with ≥60 Gy and concurrent cisplatin-based chemotherapy (CT). Tissue micro-arrays (TMAs) from a total of 221 patients were generated from surgical specimens, 201 evaluated for the SDF-1 and CXCR4 expression by immunofluorescence and correlated with clinico-pathological and outcome data.
Results: In univariate and multivariate analyses intracellular SDF-1 expression was associated with lower loco-regional control (LRC) in the entire patient group as well as in the HPV16 DNA negative subgroup. CXCR4 expression showed a trend for lower LRC in the univariate analysis which was not confirmed in the multivariate analysis. Neither for SDF-1 nor CXCR4 expression associations with distant metastasis free or overall survival were found.
Conclusions: Our exploratory data support the hypothesis that overexpression of intracellular SDF-1 is an independent negative prognostic biomarker for LRC after postoperative RT-CT in high-risk HNSCC. Prospective validation is warranted and further exploration of SDF-1/CXCR4 as a potential therapeutic target to overcome treatment resistance in HNSCC appears promising.
Aims: Carotid intima media thickness (CIMT) predicts cardiovascular (CVD) events, but the predictive value of CIMT change is debated. We assessed the relation between CIMT change and events in individuals at high cardiovascular risk.
Methods and results: From 31 cohorts with two CIMT scans (total n = 89070) on average 3.6 years apart and clinical follow-up, subcohorts were drawn: (A) individuals with at least 3 cardiovascular risk factors without previous CVD events, (B) individuals with carotid plaques without previous CVD events, and (C) individuals with previous CVD events. Cox regression models were fit to estimate the hazard ratio (HR) of the combined endpoint (myocardial infarction, stroke or vascular death) per standard deviation (SD) of CIMT change, adjusted for CVD risk factors. These HRs were pooled across studies.
In groups A, B and C we observed 3483, 2845 and 1165 endpoint events, respectively. Average common CIMT was 0.79mm (SD 0.16mm), and annual common CIMT change was 0.01mm (SD 0.07mm), both in group A. The pooled HR per SD of annual common CIMT change (0.02 to 0.43mm) was 0.99 (95% confidence interval: 0.95–1.02) in group A, 0.98 (0.93–1.04) in group B, and 0.95 (0.89–1.04) in group C. The HR per SD of common CIMT (average of the first and the second CIMT scan, 0.09 to 0.75mm) was 1.15 (1.07–1.23) in group A, 1.13 (1.05–1.22) in group B, and 1.12 (1.05–1.20) in group C.
Conclusions: We confirm that common CIMT is associated with future CVD events in individuals at high risk. CIMT change does not relate to future event risk in high-risk individuals.
Aims: Averaged measurements, but not the progression based on multiple assessments of carotid intima-media thickness, (cIMT) are predictive of cardiovascular disease (CVD) events in individuals. Whether this is true for conventional risk factors is unclear.
Methods and results: An individual participant meta-analysis was used to associate the annualised progression of systolic blood pressure, total cholesterol, low-density lipoprotein cholesterol and high-density lipoprotein cholesterol with future cardiovascular disease risk in 13 prospective cohort studies of the PROG-IMT collaboration (n = 34,072). Follow-up data included information on a combined cardiovascular disease endpoint of myocardial infarction, stroke, or vascular death. In secondary analyses, annualised progression was replaced with average. Log hazard ratios per standard deviation difference were pooled across studies by a random effects meta-analysis. In primary analysis, the annualised progression of total cholesterol was marginally related to a higher cardiovascular disease risk (hazard ratio (HR) 1.04, 95% confidence interval (CI) 1.00 to 1.07). The annualised progression of systolic blood pressure, low-density lipoprotein cholesterol and high-density lipoprotein cholesterol was not associated with future cardiovascular disease risk. In secondary analysis, average systolic blood pressure (HR 1.20 95% CI 1.11 to 1.29) and low-density lipoprotein cholesterol (HR 1.09, 95% CI 1.02 to 1.16) were related to a greater, while high-density lipoprotein cholesterol (HR 0.92, 95% CI 0.88 to 0.97) was related to a lower risk of future cardiovascular disease events.
Conclusion: Averaged measurements of systolic blood pressure, low-density lipoprotein cholesterol and high-density lipoprotein cholesterol displayed significant linear relationships with the risk of future cardiovascular disease events. However, there was no clear association between the annualised progression of these conventional risk factors in individuals with the risk of future clinical endpoints.
We measured the Coulomb dissociation of 16O into 4He and 12C at the R3B setup in a first campaign within FAIR Phase 0 at GSI Helmholtzzentrum für Schwerionenforschung, Darmstadt. The goal was to improve the accuracy of the experimental data for the 12C(α,γ)16O fusion reaction and to reach lower center-ofmass energies than measured so far.
The experiment required beam intensities of 109 16O ions per second at an energy of 500 MeV/nucleon. The rare case of Coulomb breakup into 12C and 4He posed another challenge: The magnetic rigidities of the particles are so close because of the same mass-to-charge-number ratio A/Z = 2 for 16O, 12C and 4He. Hence, radical changes of the R3B setup were necessary. All detectors had slits to allow the passage of the unreacted 16O ions, while 4He and 12C would hit the detectors' active areas depending on the scattering angle and their relative energies. We developed and built detectors based on organic scintillators to track and identify the reaction products with sufficient precision.